When it comes to skin conditions like atopic dermatitis or eczema careful bathing habits and daily skincare are essential ...

Skin, Hair, and Scalp Considerations for Black People With Atopic Dermatitis The first step in treating atopic dermatitis is working with a culturally competent dermatologist who can create a ...

As part of its ongoing 'Your Health, Our Priority' campaign, Hamad Medical Corporation (HMC) highlighted the exceptional ...

Q1 2025 net product revenue for ZORYVE® (roflumilast) was $63.8 million, a 196% increase compared to Q1 of 2024, and a 2% decrease compared to Q4 of 2024, due to typical first-quarter deductible reset ...

Arcutis Biotherapeutics Inc (ARQT) reports a remarkable 196% year-over-year revenue increase, driven by strong demand for ...

Mashable Benelux is dé plek voor alles over games, films, series, comics en gadgets. De laatste reviews en al het nieuws over ...

Data from icotrokinra ICONIC-TOTAL show 66% of patients with scalp psoriasis and 77% with genital psoriasis achieved site-specific clear or almost clear skin at Week 16Icotrokinra continues to ...

Good day, and welcome to Arcutis Biotherapeutics 2025 first-quarter financial results conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now ...

1 Gooderham, M.J. et al. Phase 3 results from an innovative trial design of treating plaque psoriasis involving difficult-to-treat, high-impact sites with icotrokinra, a targeted oral peptide that ...

Discover Arcutis Biotherapeutics' Q1 2025 earnings highlights: ZORYVE's growth, upcoming product launches, and a confident path to cash breakeven by 2026.

In addition, scalp psoriasis occurs in more than half ... by the FDA for the topical treatment of mild to moderate atopic dermatitis in patients 6 years of age and older. In 2024, ZORYVE cream ...